Carly Sisco
Family · Eau Claire, WINPI 1770230914
Payments from drug & device makers
Across 112 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$352
- Novo Nordisk$348
- Lilly USA, LLC$147
- Pfizer$108
- Exact Sciences$90
- Boehringer Ingelheim$88
- plus $635 from 20 others
What the payments were for
- Food & beverage$1,770100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $352 |
| Novo Nordisk | 26 | $348 |
| Lilly USA, LLC | 9 | $147 |
| Pfizer | 5 | $108 |
| Exact Sciences | 6 | $90 |
| Boehringer Ingelheim | 4 | $88 |
| Merck | 5 | $74 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $59 |
| Bayer | 3 | $55 |
| Johnson & Johnson | 2 | $47 |
| GSK | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Amgen | 2 | $36 |
| Novartis | 2 | $36 |
| AstraZeneca | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Biomerieux Inc | 1 | $22 |
| Ardelyx, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Viatris Specialty LLC | 1 | $15 |
| ANI Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$1,770 in reported general payments places this provider in the 85th percentile of 1,273 family providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 16 | $86 |
Paid to pharmacies, not to this prescriber.
Other family in Eau Claire
- Nicole HolmEau Claire$10K
- Carly OvergardEau Claire$5K
- Bethany StevensEau Claire$5K
- Jennifer OlsonEau Claire$4K
- Stephanie OffordMilwaukee$763K
- Laura SwobodaMenomonee Falls$111K
- Melissa BellePrentice$62K
- Lonniel BainMadison$54K
- Linda WespGlendale$44K
- Andrea BuxtonGreen Bay$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.